Vladyslav S. Sukhin

Kharkiv, Ukraine

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

Pre-operative risk stratification in apparent early-stage endometrial cancer using expert ultrasound and molecular classification: a multi-center prospective observational study (PRSTEC_multipro/CEEGOG EX-07).

Pre-operative risk stratification in apparent early-stage endometrial cancer using expert ultrasound and molecular classification: a multi-center prospective observational study (PRSTEC_multipro/CEEGOG EX-07).

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Published: June 15, 2026

Four-year survival outcomes with dostarlimab plus chemotherapy in mismatch repair deficient/microsatellite instability-high primary advanced or recurrent endometrial cancer in the RUBY trial.

Four-year survival outcomes with dostarlimab plus chemotherapy in mismatch repair deficient/microsatellite instability-high primary advanced or recurrent endometrial cancer in the RUBY trial.

Journal: Gynecologic oncology

Published: March 24, 2026

Patient-reported outcomes from the phase 3, randomized, double-blind, placebo-controlled ENGOT-cx11/GOG-3047/KEYNOTE-A18 study of pembrolizumab plus concurrent chemoradiotherapy in participants with high-risk locally advanced cervical cancer.

Patient-reported outcomes from the phase 3, randomized, double-blind, placebo-controlled ENGOT-cx11/GOG-3047/KEYNOTE-A18 study of pembrolizumab plus concurrent chemoradiotherapy in participants with high-risk locally advanced cervical cancer.

Journal: Gynecologic oncology

Published: March 10, 2025

SUCCOR 10 years: a decade's perspective on radical hysterectomy outcomes in cervical cancer.

SUCCOR 10 years: a decade's perspective on radical hysterectomy outcomes in cervical cancer.

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Published: November 07, 2024

Safety of dostarlimab in combination with chemotherapy in patients with primary advanced or recurrent endometrial cancer in a phase III, randomized, placebo-controlled trial (ENGOT-EN6-NSGO/GOG-3031/RUBY).

Safety of dostarlimab in combination with chemotherapy in patients with primary advanced or recurrent endometrial cancer in a phase III, randomized, placebo-controlled trial (ENGOT-EN6-NSGO/GOG-3031/RUBY).

Journal: Therapeutic advances in medical oncology

Published: May 21, 2024

Pembrolizumab or placebo with chemoradiotherapy followed by pembrolizumab or placebo for newly diagnosed, high-risk, locally advanced cervical cancer (ENGOT-cx11/GOG-3047/KEYNOTE-A18): a randomised, double-blind, phase 3 clinical trial.

Pembrolizumab or placebo with chemoradiotherapy followed by pembrolizumab or placebo for newly diagnosed, high-risk, locally advanced cervical cancer (ENGOT-cx11/GOG-3047/KEYNOTE-A18): a randomised, double-blind, phase 3 clinical trial.

Journal: Lancet (London, England)

Published: December 15, 2023

Prognostic factors in patients with uterine sarcoma: the SARCUT study.

Prognostic factors in patients with uterine sarcoma: the SARCUT study.

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Published: May 16, 2023

SUCCOR quality: validation of ESGO quality indicators for surgical treatment of cervical cancer.

SUCCOR quality: validation of ESGO quality indicators for surgical treatment of cervical cancer.

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Published: December 30, 2022

EVALUATION OF HORMONAL FUNCTION IN WOMEN WITH CERVICAL INSUFFICIENCY AND INFERTILITY IN THE HISTORY.

EVALUATION OF HORMONAL FUNCTION IN WOMEN WITH CERVICAL INSUFFICIENCY AND INFERTILITY IN THE HISTORY.

Journal: Wiadomosci lekarskie (Warsaw, Poland : 1960)

Published: December 13, 2021

DEVIATION BETWEEN THE PLANNED DOSE AND THE IN VIVO DOSIMETRY RESULTS DURING POSTOPERATIVE IRRADIATION IN PATIENTS WITH UTERINE CANCER DEPENDING ON ANTHROPOMETRIC DATA.

DEVIATION BETWEEN THE PLANNED DOSE AND THE IN VIVO DOSIMETRY RESULTS DURING POSTOPERATIVE IRRADIATION IN PATIENTS WITH UTERINE CANCER DEPENDING ON ANTHROPOMETRIC DATA.

Journal: Problemy radiatsiinoi medytsyny ta radiobiolohii

Published: July 20, 2021

Radical hysterectomy in early cervical cancer in Europe: characteristics, outcomes and evaluation of ESGO quality indicators.

Radical hysterectomy in early cervical cancer in Europe: characteristics, outcomes and evaluation of ESGO quality indicators.

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Published: March 04, 2021

SUCCOR cone study: conization before radical hysterectomy.

SUCCOR cone study: conization before radical hysterectomy.

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Published: February 28, 2021

Showing 1-12 of 18

Last Updated: 09/26/2026